Los Angeles Capital Management
MYOK

Los Angeles Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Los Angeles Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,983
Closed -$2.45M – 1577
2020
Q3 		$2.45M Buy
17,983
+1,177
+7% +$125K 0.01% 515
2020
Q2 		$1.62M Buy
+16,806
New +$1.4M 0.01% 679
2019
Q3 		– Sell
-17,965
Closed -$901K – 1418
2019
Q2 		$901K Buy
17,965
+510
+3% +$24.8K ﹤0.01% 876
2019
Q1 		$907K Buy
17,455
+9,150
+110% +$422K 0.01% 885
2018
Q4 		$406K Sell
8,305
-325
-4% -$17.9K ﹤0.01% 1018
2018
Q3 		$563K Sell
8,630
-12,540
-59% -$737K ﹤0.01% 1068
2018
Q2 		$1.05M Buy
21,170
+6,990
+49% +$338K 0.01% 878
2018
Q1 		$692K Buy
+14,180
New +$737K ﹤0.01% 938

Los Angeles Capital Management's MYOK Position: Q4 2020 in Review

Los Angeles Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 17,983 shares — an estimated $2.45M sold.

Los Angeles Capital Management first reported a position in MYOK in Q1 2018 and held it in 8 quarters. The position peaked at $2.45M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Los Angeles Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Los Angeles Capital Management sold 17,983 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.45M.
  • Los Angeles Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 8 quarters.
  • Los Angeles Capital Management's MyoKardia, Inc. Common Stock position peaked at $2.45M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Los Angeles Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.